Fortune MNC 500 India 2026 edition
Rank#249- Total income
- ₹2,733 Cr
- Profit
- ₹185 Cr
Last year #237
Sandoz Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2,778.2 Cr
▼ 2% YoY
Net profit · FY 2025
₹162.26 Cr
Net margin 5.8%
EBITDA · FY 2025
₹405.99 Cr
EBITDA margin 14.6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.2 Cr
Issued & subscribed
Satisfied charges
₹133 Cr
No open charges
Company age
31 yrs
Est. 1995
Employees · EPFO
1,661
Provident fund records
About Sandoz Private Limited
Data last updated:
Sandoz Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India, a subsidiary of Novartis Ag Holding. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 1995 and has been in existence for over 31 years.
Sandoz is ranked #249 on the Fortune MNC 500 India (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1995PTC086989. Its GSTIN is 27AAACS9267J1ZU (Maharashtra). The company holds 25 GST registrations, of which 9 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.2 Cr. It was formerly known as Sandoz Pharma (India) Private Limited. It is led by directors including Monaz Noble and Sudhir Trambakrao Bhandare.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹2,778.2 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹162.26 Cr (net margin 5.8%) and EBITDA of ₹405.99 Cr (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 13% over five years.
The company has about 1,661 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Sandoz. As per MCA filings, the company has satisfied charges of ₹133 Cr on record. Court records list 112 cases involving the company, including 59 filed by the company and 53 filed against it; 30 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in August 2023. Its 10 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Cadila Pharmaceuticals Limited with revenue of ₹3,869.17 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2023, listing 3,592 overdue payments to 187 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sandoz.com.
Company details
CIN U24230MH1995PTC086989
Registration Number 086989
Incorporation Date 30 March 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Novartis Ag Holding
Compliance Status Active Compliant
Recognitions & Rankings of Sandoz
Contact details
Sandoz Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is sandoz.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKalwe MIDC Plot No. 8 – A/2 8/B Ttc Industrial Area Kalwe Block Villag, E Dighe, Navi Mumbai, Maharashtra, India – 400708
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sandoz Private Limited, buy the company report.
Comprehensive company report
Sandoz Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Sandoz operates one associated brand: Sandoz. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Generic and biosimilar pharmaceuticals are developed and distributed globally. | sandoz.com |
Business activity
The main business activities of Sandoz are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Sandoz Private Limited, buy the company report.
Financials of Sandoz Private Limited
FY 2025 filings availableSandoz Private Limited reported revenue of ₹2,778.2 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹2,778.2 Cr ▼ 2%
Net profit · FY 2025
₹162.26 Cr margin 5.8%
EBITDA · FY 2025
₹405.99 Cr margin 14.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 18%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 41%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹405.99 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹162.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.6% | ||||
| Net Profit Margin | 5.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sandoz Private Limited, buy the company report.
Board of directors of Sandoz Private Limited
Sandoz has 4 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monaz Noble Also directs: Godrej Industries Limited | Director | 27 Sep 2023 | 3 Years 1 Months | Current |
| Sudhir Trambakrao Bhandare | Director | 05 Dec 2018 | 7 Years 10 Months | Current |
| Sairam Kesavan Nair | Director | 03 Aug 2024 | 2 Years 2 Months | Current |
| Michael Leonard Banks | Director | 13 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Sandoz Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cadila Pharmaceuticals Limited | ₹3,869.17 Cr (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Acg Associated Capsules Private Limited | ₹3,600.7 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Shreya Life Sciences Private Limited | ₹2,946.23 Cr (FY 2025) | 284.0% | Mumbai, Maharashtra, India | |||
| Amneal Pharmaceuticals Private Limited | ₹2,944.87 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Eris Lifesciences Limited | ₹2,912 Cr (FY 2025) | 43.0% | Ahmedabad, Gujarat, India | |||
| Sandoz Private Limitedthis company | ₹2,778.2 Cr (FY 2025) | ₹162.26 Cr | 5.8% | -2.0% | 1,661 | Navi Mumbai, Maharashtra, India |
| Biological E. Limited | ₹2,708 Cr (FY 2024) | -30.0% | Telangana, India | |||
| Pfizer Limited | ₹2,453.6 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Marksans Pharma Limited | ₹2,227.83 Cr (FY 2024) | 17.0% | Mumbai, Maharashtra, India | |||
| Merck Life Science Private Limited | ₹2,200.06 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| FDC Limited | ₹2,198.78 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sandoz Private Limited, buy the company report.
Auditor
Sandoz Private Limited is audited by Deloitte Haskins and Sells LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins and Sells LLP | FY 2022 | 117366W/W-100018 |
Shareholding
The shareholding of Sandoz Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sandoz Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹133 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2003 | 90158196 | Standard Chartered Bank | ₹108 Cr | Satisfied | |
| 06 Dec 1999 | 90157354 | Banque National De Paris | ₹5 Cr | Satisfied | |
| 19 Mar 1999 | 90157117 | Union Bank of India | ₹10 Cr | Satisfied | |
| 10 Apr 1997 | 90156560 | Standard Chartered Bank | ₹10 Cr | Satisfied |
To see the full charge records of Sandoz Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Sandoz Private Limited has 1 deal on record (1 secondary share transfer); the latest was in August 2023.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Secondary share transfer | Undisclosed | Buyer: Sandoz Ag Seller: Novartis Holding Ag |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sandoz Private Limited has 112 court cases on record: 59 filed by Sandoz, 53 filed against it. 30 cases are pending and 82 are disposed.
Total cases
112
Filed by the company
59
Filed against the company
53
Pending
30
Disposed
82
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 56 | 16 | 12 |
| District courts | 51 | 34 | 17 |
| Supreme Court | 5 | 3 | 1 |
Cases on record (5 of 112)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against Government of Maharashtra and Ors. | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed against the company by Clariant Chemicals (India) Ltd. | Pending |
| District court, Maharashtra Industrial and Lab, Maharashtra | Interim or miscellaneous application | Filed by the company against an individual | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by The PR Commissioner of Income Tax 8 Mumbai | Pending |
| High Court | Court case (MVXA) | Filed by the company against State of Maharashta and 1 other | Pending |
To see the full case history of Sandoz Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sandoz Private Limited has 15 MSME Form 1 returns on record between 2019 and 2023, listing 3,592 overdue payments to 187 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 187)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rishida Engineering Corporation | |||
| an individual supplier | |||
| Transchem Corporation Pharma Private Limited | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Sandoz Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sandoz Private Limited has a workforce of 1,661 employees on its EPFO records as of Apr 06, 2024, across 3 active EPFO establishments.
Employee count
1,661
Active EPFO establishments
3
Employee growth
105.06%
GST
Sandoz has 25 GST registrations: 9 active and 16 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
25
Active
9
Cancelled / inactive
16
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACS9267J1ZU | Maharashtra | Active | 01 Jul 2017 |
| 02AAACS9267J1Z6 | Himachal Pradesh | Active | 01 Jul 2017 |
| 06AAACS9267J1ZY | Haryana | Active | 01 Jul 2017 |
| 07AAACS9267J1ZW | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sandoz Private Limited, buy the company report.
Recent activity
Sandoz Private Limited has 30 board changes on record since 2007: 4 appointments and 26 cessations. The latest: Michael Leonard Banks was appointed as Director on 13 Feb 2025.
AGM
Sandoz Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records.
Filing
Sandoz Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Michael Leonard Banks was appointed as Director.
Ceased
Sairam Kesavan Nair ceased to be Additional Director.
Appointed
Sairam Kesavan Nair was appointed as Director.
Ceased
Vandana Singh ceased to be Additional Director.
Ceased
Monaz Noble ceased to be Additional Director.
Appointed
Monaz Noble was appointed as Director.
Charges
A charge registered on 27 Jun 2003 via Charge ID 90158196 with Standard Chartered Bank was fully satisfied on 15 Sep 2023.
Ceased
Rajeev Ranjan ceased to be Additional Director.
Ceased
Nishith Laxmikant Vaidya ceased to be Director.
Ceased
Sanjeev Shrivastav ceased to be Additional Director.
32 earlier events are in the company report.
News
Frequently asked questions
Sandoz is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 1995 (31+ years old) and is registered under CIN U24230MH1995PTC086989.
Sandoz has 4 current directors:
- Monaz Noble - Director
- Sudhir Trambakrao Bhandare - Director
- Sairam Kesavan Nair - Director
- Michael Leonard Banks - Director
The latest financial statements of Sandoz on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sandoz is 27AAACS9267J1ZU, registered in Maharashtra. The company has 25 GST registrations in all, of which 9 are active and 16 are cancelled or inactive. Other active GSTINs include 02AAACS9267J1Z6 (Himachal Pradesh), 06AAACS9267J1ZY (Haryana), 07AAACS9267J1ZW (Delhi).
The CIN (Corporate Identification Number) of Sandoz is U24230MH1995PTC086989. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sandoz has 112 court cases on record: 59 filed by the company and 53 filed against it. 30 are pending. Most are in the high courts.
Sandoz was incorporated on 30 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Sandoz has 1 deal on record (1 secondary share transfer); the latest was in August 2023.
The peers of Sandoz by revenue are Cadila Pharmaceuticals Limited, Acg Associated Capsules Private Limited, Shreya Life Sciences Private Limited, Amneal Pharmaceuticals Private Limited, Eris Lifesciences Limited and 5 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Michael Leonard Banks was appointed as Director on 13 Feb 2025. Sairam Kesavan Nair ceased to be Additional Director on 26 Sep 2024. Sairam Kesavan Nair was appointed as Director on 03 Aug 2024. Sandoz has 30 board changes on record in total.
Sandoz has 15 MSME Form 1 returns on record between 2019 and 2023, listing 3,592 overdue payments to 187 micro and small suppliers. The latest return was filed on 29 Apr 2023.
Sandoz can be reached through the website sandoz.com. Its registered office is in Navi Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages